These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 18758238)
41. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology]. Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576 [TBL] [Abstract][Full Text] [Related]
42. S-Phase entry upon ectopic expression of G1 cyclin-dependent kinases in the absence of retinoblastoma protein phosphorylation. Leng X; Connell-Crowley L; Goodrich D; Harper JW Curr Biol; 1997 Sep; 7(9):709-12. PubMed ID: 9285720 [TBL] [Abstract][Full Text] [Related]
43. Role of cyclins and cyclin-dependent kinases in pluripotent stem cells and their potential as a therapeutic target. Jirawatnotai S; Dalton S; Wattanapanitch M Semin Cell Dev Biol; 2020 Nov; 107():63-71. PubMed ID: 32417217 [TBL] [Abstract][Full Text] [Related]
44. [Cell cycle and parathyroid tumor]. Matsushime H Nihon Rinsho; 1995 Apr; 53(4):844-9. PubMed ID: 7752470 [TBL] [Abstract][Full Text] [Related]
45. Cell cycle transcriptomics of Capsaspora provides insights into the evolution of cyclin-CDK machinery. Pérez-Posada A; Dudin O; Ocaña-Pallarès E; Ruiz-Trillo I; Ondracka A PLoS Genet; 2020 Mar; 16(3):e1008584. PubMed ID: 32176685 [TBL] [Abstract][Full Text] [Related]
46. Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs. Roskoski R Pharmacol Res; 2019 Jan; 139():471-488. PubMed ID: 30508677 [TBL] [Abstract][Full Text] [Related]
47. Impairment of rat postnatal lung alveolar development by glucocorticoids: involvement of the p21CIP1 and p27KIP1 cyclin-dependent kinase inhibitors. Corroyer S; Schittny JC; Djonov V; Burri PH; Clement A Pediatr Res; 2002 Feb; 51(2):169-76. PubMed ID: 11809910 [TBL] [Abstract][Full Text] [Related]
48. Role of CDK/cyclin complexes in transcription and RNA splicing. Loyer P; Trembley JH; Katona R; Kidd VJ; Lahti JM Cell Signal; 2005 Sep; 17(9):1033-51. PubMed ID: 15935619 [TBL] [Abstract][Full Text] [Related]
49. Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors. Pavletich NP J Mol Biol; 1999 Apr; 287(5):821-8. PubMed ID: 10222191 [TBL] [Abstract][Full Text] [Related]
50. The role of controlled proteolysis in cell-cycle regulation. Udvardy A Eur J Biochem; 1996 Sep; 240(2):307-13. PubMed ID: 8841392 [TBL] [Abstract][Full Text] [Related]
51. Driving the cell cycle with a minimal CDK control network. Coudreuse D; Nurse P Nature; 2010 Dec; 468(7327):1074-9. PubMed ID: 21179163 [TBL] [Abstract][Full Text] [Related]
52. All aboard the cyclin train: subcellular trafficking of cyclins and their CDK partners. Yang J; Kornbluth S Trends Cell Biol; 1999 Jun; 9(6):207-10. PubMed ID: 10354564 [TBL] [Abstract][Full Text] [Related]
53. Hysteresis and cell cycle transitions: how crucial is it? Han Z; Yang L; MacLellan WR; Weiss JN; Qu Z Biophys J; 2005 Mar; 88(3):1626-34. PubMed ID: 15626707 [TBL] [Abstract][Full Text] [Related]
54. In the wrong place at the wrong time: does cyclin mislocalization drive oncogenic transformation? Moore JD Nat Rev Cancer; 2013 Mar; 13(3):201-8. PubMed ID: 23388618 [TBL] [Abstract][Full Text] [Related]
55. Cell cycle, cytoskeleton dynamics and beyond: the many functions of cyclins and CDK inhibitors. Bendris N; Lemmers B; Blanchard JM Cell Cycle; 2015; 14(12):1786-98. PubMed ID: 25789852 [TBL] [Abstract][Full Text] [Related]
56. Evidence that a free-running oscillator drives G1 events in the budding yeast cell cycle. Haase SB; Reed SI Nature; 1999 Sep; 401(6751):394-7. PubMed ID: 10517640 [TBL] [Abstract][Full Text] [Related]
58. Temporal patterns of gene expression of G1-S cyclins and cdks during the first and second mitotic cell cycles in mouse embryos. Moore GD; Ayabe T; Kopf GS; Schultz RM Mol Reprod Dev; 1996 Nov; 45(3):264-75. PubMed ID: 8916036 [TBL] [Abstract][Full Text] [Related]